Eyenovia, Inc.

NasdaqCM:EYEN Stock Report

Market Cap: US$9.5m

Eyenovia Management

Management criteria checks 2/4

Eyenovia's CEO is Michael Rowe, appointed in Jul 2018, has a tenure of 6.42 years. total yearly compensation is $775.47K, comprised of 74.1% salary and 25.9% bonuses, including company stock and options. directly owns 0.099% of the company’s shares, worth $9.38K. The average tenure of the management team and the board of directors is 0.9 years and 2.8 years respectively.

Key information

Michael Rowe

Chief executive officer

US$775.5k

Total compensation

CEO salary percentage74.1%
CEO tenure6.4yrs
CEO ownership0.1%
Management average tenureless than a year
Board average tenure2.8yrs

Recent management updates

Recent updates

Is Eyenovia (NASDAQ:EYEN) Weighed On By Its Debt Load?

Jan 30
Is Eyenovia (NASDAQ:EYEN) Weighed On By Its Debt Load?

Is Eyenovia (NASDAQ:EYEN) Using Debt In A Risky Way?

Oct 14
Is Eyenovia (NASDAQ:EYEN) Using Debt In A Risky Way?

Is Eyenovia (NASDAQ:EYEN) Using Debt Sensibly?

Jun 27
Is Eyenovia (NASDAQ:EYEN) Using Debt Sensibly?

Does Eyenovia (NASDAQ:EYEN) Have A Healthy Balance Sheet?

Oct 25
Does Eyenovia (NASDAQ:EYEN) Have A Healthy Balance Sheet?

Eyenovia gains as H.C. Wainwright initiates with Buy on pipeline potential

Oct 05

CEO Compensation Analysis

How has Michael Rowe's remuneration changed compared to Eyenovia's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$38m

Jun 30 2024n/an/a

-US$37m

Mar 31 2024n/an/a

-US$32m

Dec 31 2023US$775kUS$575k

-US$27m

Sep 30 2023n/an/a

-US$25m

Jun 30 2023n/an/a

-US$25m

Mar 31 2023n/an/a

-US$26m

Dec 31 2022US$1mUS$512k

-US$28m

Sep 30 2022n/an/a

-US$19m

Jun 30 2022n/an/a

-US$17m

Mar 31 2022n/an/a

-US$15m

Dec 31 2021US$1mUS$360k

-US$13m

Sep 30 2021n/an/a

-US$20m

Jun 30 2021n/an/a

-US$19m

Mar 31 2021n/an/a

-US$20m

Dec 31 2020US$665kUS$275k

-US$20m

Sep 30 2020n/an/a

-US$21m

Jun 30 2020n/an/a

-US$20m

Mar 31 2020n/an/a

-US$21m

Dec 31 2019US$482kUS$275k

-US$21m

Compensation vs Market: Michael's total compensation ($USD775.47K) is about average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.

CEO

Michael Rowe (62 yo)

6.4yrs

Tenure

US$775,468

Compensation

Mr. Michael M. Rowe serves as Chief Executive Officer at Eyenovia, Inc. since August 01, 2022 and is its Director since August 2022 and serves as its President since 2024. He had been Chief Operating Offic...

Leadership Team

NamePositionTenureCompensationOwnership
Michael Rowe
CEO, President & Director6.4yrsUS$775.47k0.099%
$ 9.4k
Tsontcho Ianchulev
Co-Founder & Executive Directorno dataUS$247.50k0.32%
$ 30.2k
Bren Kern
COO & Corporate VP1.9yrsUS$566.99k0.0022%
$ 212.9
Andrew Jones
CFO, Secretary & Treasurerless than a yearno datano data
Tony Cardinale
Vice President of Salesless than a yearno datano data
Norbert Lowe
Senior Vice President of Commercial Operationsless than a yearno datano data
Alexander Lobo
Investor Contactno datano datano data

0.9yrs

Average Tenure

51.5yo

Average Age

Experienced Management: EYEN's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Michael Rowe
CEO, President & Director2.3yrsUS$775.47k0.099%
$ 9.4k
Tsontcho Ianchulev
Co-Founder & Executive Director10.8yrsUS$247.50k0.32%
$ 30.2k
Charles Mather
Independent Chairman of the Board6.8yrsUS$148.75k0.085%
$ 8.1k
Michael Geltzeiler
Independent Director1.1yrsUS$57.83k0.018%
$ 1.7k
Robert Weinreb
Member of Scientific Advisory Boardno datano datano data
Ellen Strahlman
Independent Director2.4yrsUS$162.50k0.067%
$ 6.4k
James Tsai
Member of Scientific Advisory Boardno datano datano data
Ram Palanki
Independent Director2.4yrsUS$140.00k0.034%
$ 3.2k
Pamela Gallin
Member of Scientific Advisory Boardno datano datano data
Mark Bullimore
Member of Scientific Advisory Board5yrsno datano data
April Jasper
Member of Scientific Advisory Board5yrsno datano data
Rachel Jacobson
Independent Director2.8yrsUS$145.00k0.038%
$ 3.6k

2.8yrs

Average Tenure

62yo

Average Age

Experienced Board: EYEN's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 04:44
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eyenovia, Inc. is covered by 9 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jonathan AschoffB. Riley Wealth
Brian Kemp DolliverBrookline Capital Markets
Matthew CaufieldH.C. Wainwright & Co.